EN DE

CME Group (7018) Fair Value & Analysis

Consumer Cyclical · MY · Market cap 6.0M MYR

CG CME Group 7018 · KLSE
Price0.0050 MYR
Fair Value0.0080 MYR
Upside+60.0%
Quality43/100
Watch CME Group for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -57.7% net margin
Low debt · generates free cash flow
Mixed vs. peers (4/9)
Narrow moat 19/100
Evidence: High Range 0.0079 MYR – 0.0082 MYR Share as image

Fair value as of: Jul 16, 2026

From 24 valuation models · updated 25 days ago

Share price −50.0% over the past month.

Below-average quality, screening 60% undervalued on our models.

What matters now

  • The large discount to fair value meets weak quality (43/100). That raises the risk this is a value trap rather than a bargain.
  • The price is below even our cautious bear case (0.0079 MYR). The market is more pessimistic than our downside scenario.
  • The models converge in a tight band (0.0079 MYR to 0.0082 MYR), unusually little disagreement for a valuation.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

0.1450 MYR 0.0050 MYR Fair Value 0.0080 MYR Jun 2020 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.

How to read this chart

60‑month range 0.0050 MYR – 0.1450 MYR · fair‑value band 0.0079 MYR – 0.0082 MYR · the 0.0050 MYR price screens below the 0.0080 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 16, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

CME Group (7018) currently trades at 0.0050 MYR, while our model-based Fair Value estimate is 0.0080 MYR, implying the stock looks roughly 60.0% undervalued today. The Quality Score stands at 43/100 (below-average quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, CME Group generated revenue of 18.2M MYR at a net margin of -57.7%. Revenue declined 16.8% year over year. Net debt stands at 25.3M MYR. Fundamentals as of Jul 16, 2026

Our scenario range runs from 0.0079 MYR (bear case) to 0.0082 MYR (bull case); at 0.0050 MYR, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 67% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at 25% fair-value upside, at 60%, 7018 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 0.0200 MYR 0.0300 MYR 0.0500 MYR 80
Rev-Margin DCF 0.0300 MYR 0.0600 MYR 0.1000 MYR 74
ROIC Compounder 0.0400 MYR 0.0500 MYR 0.0600 MYR 72
All 24 models by family
DCF Models
FCF DCF 0.0300 MYR 0.0300 MYR 0.0600 MYR 38
Owner Earnings 0.0800 MYR 0.1600 MYR 0.2900 MYR 31
5Y Revenue Exit 0.0300 MYR 0.0500 MYR 0.1000 MYR 39
5Y EBITDA Exit 0.0500 MYR 0.0900 MYR 0.1600 MYR 41
5Y P/E Exit 0.0800 MYR 0.1900 MYR 0.3400 MYR 38
10Y Revenue Exit 0.0300 MYR 0.0500 MYR 0.0800 MYR 36
10Y EBITDA Exit 0.0400 MYR 0.0800 MYR 0.1700 MYR 37
10Y P/E Exit 0.0600 MYR 0.1500 MYR 0.3000 MYR 35
Earnings-Based
Graham-Dodd 0.0500 MYR 0.3300 MYR 0.4600 MYR 54
Lynch FV 0.1100 MYR 0.1600 MYR 0.2100 MYR 50
PEG = 1.0 0.1100 MYR 0.1600 MYR 0.2100 MYR 46
EPV 0.0400 MYR 0.0500 MYR 0.0500 MYR 59
Multiples
P/E Multiple 0.1100 MYR 0.1500 MYR 0.1900 MYR 63
P/S Multiple 0.0300 MYR 0.0400 MYR 0.0500 MYR 58
P/B Multiple 0.0900 MYR 0.1200 MYR 0.1500 MYR 55
EV/EBIT 0.0900 MYR 0.1200 MYR 0.1400 MYR 53
EV/EBITDA 0.0600 MYR 0.0800 MYR 0.1000 MYR 54
EV/Revenue 0.0300 MYR 0.0400 MYR 0.0600 MYR 43
Asset-Based
NCAV (Graham) 0.0200 MYR 0.0300 MYR 0.0500 MYR 50
Growth DCF
Growth DCF 0.0200 MYR 0.0300 MYR 0.0500 MYR 80
Rev-Margin DCF 0.0300 MYR 0.0600 MYR 0.1000 MYR 74
Economic Profit
Residual Income 0.0400 MYR 0.0500 MYR 0.0900 MYR 61
ROIC Compounder 0.0400 MYR 0.0500 MYR 0.0600 MYR 72
Growth Earnings
Growth-Adj P/E 0.1500 MYR 0.2100 MYR 0.2800 MYR 68

Widest divergence: Growth Earnings (0.2100 MYR) versus Asset-Based (0.0300 MYR). Highest evidence: Growth DCF (80).

Notify me when 7018 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 18.2M MYR
Revenue growth (YoY) -16.8%
Net margin -57.7%
Return on equity 1,717%
Free cash flow 2.1M MYR FY2025
Operating margin -6.0%
More key figures
EPS growth (YoY) +65.2%
Net debt 25.3M MYR FY2025

Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 43/100

Of which business quality 46 · Market factors (momentum, volatility) 17

Profitability 46
Margins and returns on capital today
Quality Growth 68
Are margins and returns improving?
Cashflow 43
Earnings quality: real cash, not paper profit
Fin. Strength 41
Balance sheet, leverage, solvency risk
Investment 86
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 5
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 4
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

CME Group Berhad, an investment holding company, designs, manufactures, sells, and services firefighting and specialist vehicles in Malaysia. The company operates through four segments: Investment Holding, Manufacturing, Trading, and Others. It offers specialized mobility vehicles, and firefighting and safety vehicles.

Full company description

CME Group Berhad, an investment holding company, designs, manufactures, sells, and services firefighting and specialist vehicles in Malaysia. The company operates through four segments: Investment Holding, Manufacturing, Trading, and Others. It offers specialized mobility vehicles, and firefighting and safety vehicles. The company also offers specialist vehicles, airport crash tenders, hazmat vehicles, aerial access ladder, cranes, fuel transfer vehicles, refuellers, riot control vehicles, fire rescue equipment, rescue equipment, and fixed installations. In addition, it services its firefighting and specialist vehicles; sale of related spare parts; sales and services of firefighting equipment, firefighting gas system, specialist and firefighting vehicles, and other safety related products; and designs, manufactures, and fire engine. Further, the company trades and deals in various pharmaceutical, medicinal, biological, and health supplement, and related health care products, as well as engages in property development. The company was incorporated in 1979 and is based in Subang Jaya, Malaysia.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2020 – FY2025 · reported fiscal years

CME Group reported revenue of 39.9M MYR in FY2025 versus 4.1M MYR in FY2020, a compound +57.3%/yr. Reported net income was 8.4M MYR in FY2025, compounding +27.4%/yr from FY2020.

Growth Quality 67/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
39.9M MYR
Latest YoY
+46.7%
Avg. growth/yr (13Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.3%
Revenue +57.3%/yr
FY20 4.1M MYR
FY21 16.0M MYR
FY23 12.9M MYR
FY24 27.2M MYR
FY25 39.9M MYR
Net income +27.4%/yr
FY20 2.5M MYR
FY21 −5.1M MYR
FY23 −2.1M MYR
FY24 −2.5M MYR
FY25 8.4M MYR

Watch 7018: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "CME Group Fair Value". https://www.fairvalue-calculator.com/stock/7018

Peer Group

Auto Manufacturers · 119 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 43 · Below median
Fair Value upside +60% · Top 25%
Return on assets 2% · Below median
Net margin (TTM) -58% · Bottom 25%
Operating margin (TTM) -6% · Bottom 25%
Revenue growth -17% · Bottom 25%

Valuation Multiples vs Auto Manufacturers median · lower = cheaper

P/S (TTM) 0.08× · Cheaper than 75% of peers
P/FCF 0.7× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 27
FUTURE 0 · sector 33
PAST 0 · sector 19
HEALTH 100 · sector 94
DIVIDEND 0 · sector 44

Insider activity: 40/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Auto Manufacturers stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).

Stock Price Fair Value vs Fair Value
Toyota Motor Corporation TM $179.76 $224.63 +25%
BYD Company 81211 HK$80.55 HK$50.85 -37%
Hyundai Motor Company 005380 425,000 KRW 616,918 KRW +45%
General Motors Company GM $77.72 $56.93 -27%
Bayerische Motoren Werke Aktiengesellschaft BMWM5N 1,909 MXN 2,944 MXN +54%
Ferrari N.V RACE $376.64 $228.05 -39%
Ford Motor Company F C$11.86 C$4.00 -66%
Mercedes-Benz Group BENZ C$20.44 C$35.15 +72%
Volkswagen AG VOW 2,149 CZK 7,191 CZK +235%
Maruti Suzuki India Limited MARUTI ₹13,803 ₹8,236 -40%

Compare CME Group with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is CME Group (7018) overvalued or undervalued?
As of Jul 16, 2026, our model estimates a fair value of 0.0080 MYR versus a price of 0.0050 MYR, about +60% (undervalued).
What is the fair value of 7018?
Our model-based fair value for CME Group is 0.0080 MYR (as of Jul 16, 2026), built from audited fundamentals. The current price is 0.0050 MYR.
What is the quality score of 7018?
CME Group has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of CME Group (7018)?
CME Group reported trailing-twelve-month revenue of about 18.2M MYR (latest available figure, as of Jul 16, 2026).
What is the net profit margin of 7018?
The net profit margin of CME Group is about -57.7%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track CME Group and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.